Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Sales/Fixed Asset

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Sales/Fixed Asset(x) 1.141.251.240.890.76

What is the latest Sales/Fixed Asset ratio of NATCO PHARMA ?

The latest Sales/Fixed Asset ratio of NATCO PHARMA is 1.14 based on Mar2026 Consolidated results.
Year Sales/Fixed Asset
Mar20261.14
Mar20251.25
Mar20241.24
Mar20230.89
Mar20220.76

How is Sales/Fixed Asset of NATCO PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2026 1.14
-8.80
Mar2025 1.25
0.81
Mar2024 1.24
39.33
Mar2023 0.89
17.11
Mar2022 0.76 -

Other Financial Ratios of NATCO PHARMA


Compare Sales/Fixed Asset ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,576.9 Cr -0.2% -8.3% -5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0.2%

-8.3%

-5.1%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses